Global D
5
2
3
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.4% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Prospective Study to Evaluate the Performance and the Safety of Global D's Implants of Craniomaxillofacial Surgery (CMF) Ranges Indicated for Trauma Surgery (CMF-TRAUMA)
Role: lead
Prospective Study to Evaluate the Performance and Safety of Personalized Implants in Cranio-Maxillofacial (CMF) Surgery Indicated for Orthognathic Surgery
Role: lead
Study Evaluating the Performance and Safety of Global D Implants Indicated for Orthognathic Surgery
Role: lead
Study Evaluating the Performance and Safety in the Medium and Long Term of Global D ZygoFixU System
Role: lead
Study Evaluating the Performance and Safety in the Medium and Long Term of Global D Implant-prosthetic Systems
Role: lead
All 5 trials loaded